SWOG clinical trial number
30904

A Prospective Randomized Phase III Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma

Closed
Phase
Published
Abbreviated Title
Renal
Activated
05/15/2000
Closed
01/13/2003
Participants
NCORP, Members, UCOP, Medical Oncologists, Surgeons, Pathologists

Research committees

Genitourinary Cancer

Eligibility Criteria Expand/Collapse

Pt must have solitary T1-T2 renal tumors, suspicious for renal adenocarcinoma in the presence of a normal contralateral kidney. Tumor must be well located so that surgery can be safely done in healthy tissue; should not exceed 5 cm in diameter; must be single on CT scan; does not show evidence of invasion of the perirenal fat (T1-T2) on CT or IVU. Pt must have N0, M0 disease, be fit for surgery with a WHO performance status of less than 2. Pt must not have a solitary kidney, von Hippel-Lindau disease, multifocal disease, T3-T4 tumors, clinical presence of distant or lymphatic mets nor a WHO performance status of greater than 2.

Publication Information Expand/Collapse

2014

Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904

E Scosyrev;EM Messing;R Sylvester;S Campbell;H van Poppe European Urology 65(2):372-377;

PMid: PMID23850254 | PMC number: not available